Timing of systemic therapy relative to stereotactic radiosurgery for brain metastases: a real-world cohort study
Combining stereotactic radiosurgery (SRS) with systemic therapy is increasingly common for brain metastases, yet real-world evidence on immunotherapy timing relative to SRS remains limited. We evaluated the association of immunotherapy and its timing with survival, intracranial control and toxicity, with exploratory an...